de Paulis T, Kumar Y, Johansson L, Rämsby S, Florvall L, Hall H, Angeby-Möller K, Ogren S O
J Med Chem. 1985 Sep;28(9):1263-9. doi: 10.1021/jm00147a025.
A series of substituted 6-methoxysalicylamides were synthesized from their corresponding 2,6-dimethoxybenzamides by demethylation of one methoxy group with boron tribromide. Substituted 6-methoxysalicylamides having a lipophilic aromatic substituent in the 3-position para with respect to the methoxy group, e.g. a bromo or an iodo atom or an ethyl or a propyl group, and having an (S)-N-(1-alkyl-2-pyrrolidinyl)methyl moiety as the side chain were found to be potent blockers of [3H]spiperone binding in vitro and potent inhibitors of the apomorphine syndrome in the rat. Similar to remoxipride but in contrast to haloperidol, some of the substituted salicylamides show a 10-20-fold separation between the dose that inhibits hyperactivity and that which inhibits stereotypy. It was concluded that, besides the requirement of a lipophilic substituent in the position para to the methoxy group for antidopamine activity in vivo, the formation of a coplanar six-membered pseudoring involving the amide moiety and the methoxy group is a structural requirement for activity in vitro.
通过用三溴化硼使相应的2,6 - 二甲氧基苯甲酰胺的一个甲氧基脱甲基化,合成了一系列取代的6 - 甲氧基水杨酰胺。发现3 - 位相对于甲氧基处于对位且具有亲脂性芳族取代基(例如溴或碘原子或乙基或丙基)并且具有(S)-N-(1 - 烷基 - 2 - 吡咯烷基)甲基部分作为侧链的取代的6 - 甲氧基水杨酰胺在体外是[3H]螺哌隆结合的有效阻断剂,并且是大鼠阿扑吗啡综合征的有效抑制剂。与瑞莫必利相似但与氟哌啶醇相反,一些取代的水杨酰胺在抑制多动的剂量和抑制刻板行为的剂量之间显示出10 - 20倍的差异。得出的结论是,除了在体内抗多巴胺活性中在甲氧基对位需要亲脂性取代基之外,涉及酰胺部分和甲氧基的共面六元假环的形成是体外活性的结构要求。